Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW.

J Clin Invest. 2007 Mar;117(3):746-56.


The HDL proteome: a marker--and perhaps mediator--of coronary artery disease.

Heinecke JW.

J Lipid Res. 2009 Apr;50 Suppl:S167-71. doi: 10.1194/jlr.R800097-JLR200. Epub 2008 Dec 5.


Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.

Vaisar T, Shao B, Green PS, Oda MN, Oram JF, Heinecke JW.

Curr Atheroscler Rep. 2007 Nov;9(5):417-24.


Combined statin and niacin therapy remodels the high-density lipoprotein proteome.

Green PS, Vaisar T, Pennathur S, Kulstad JJ, Moore AB, Marcovina S, Brunzell J, Knopp RH, Zhao XQ, Heinecke JW.

Circulation. 2008 Sep 16;118(12):1259-67. doi: 10.1161/CIRCULATIONAHA.108.770669. Epub 2008 Sep 2.


HDL in humans with cardiovascular disease exhibits a proteomic signature.

Vaisar T, Mayer P, Nilsson E, Zhao XQ, Knopp R, Prazen BJ.

Clin Chim Acta. 2010 Jul 4;411(13-14):972-9. doi: 10.1016/j.cca.2010.03.023. Epub 2010 Mar 20.


The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.

Alwaili K, Bailey D, Awan Z, Bailey SD, Ruel I, Hafiane A, Krimbou L, Laboissiere S, Genest J.

Biochim Biophys Acta. 2012 Mar;1821(3):405-15. doi: 10.1016/j.bbalip.2011.07.013. Epub 2011 Jul 23.


Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.

Pamir N, Hutchins P, Ronsein G, Vaisar T, Reardon CA, Getz GS, Lusis AJ, Heinecke JW.

J Lipid Res. 2016 Feb;57(2):246-57. doi: 10.1194/jlr.M063701. Epub 2015 Dec 15.


A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.

Shao B, de Boer I, Tang C, Mayer PS, Zelnick L, Afkarian M, Heinecke JW, Himmelfarb J.

J Proteome Res. 2015 Jul 2;14(7):2792-806. doi: 10.1021/acs.jproteome.5b00060. Epub 2015 Jun 15.


Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.

Shah AS, Tan L, Long JL, Davidson WS.

J Lipid Res. 2013 Oct;54(10):2575-85. doi: 10.1194/jlr.R035725. Epub 2013 Feb 24. Review.


Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.

Pennathur S, Bergt C, Shao B, Byun J, Kassim SY, Singh P, Green PS, McDonald TO, Brunzell J, Chait A, Oram JF, O'brien K, Geary RL, Heinecke JW.

J Biol Chem. 2004 Oct 8;279(41):42977-83. Epub 2004 Aug 2.


Psoriasis alters HDL composition and cholesterol efflux capacity.

Holzer M, Wolf P, Curcic S, Birner-Gruenberger R, Weger W, Inzinger M, El-Gamal D, Wadsack C, Heinemann A, Marsche G.

J Lipid Res. 2012 Aug;53(8):1618-24. doi: 10.1194/jlr.M027367. Epub 2012 May 30.


Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease.

Krishnan S, Huang J, Lee H, Guerrero A, Berglund L, Anuurad E, Lebrilla CB, Zivkovic AM.

J Proteome Res. 2015 Dec 4;14(12):5109-18. doi: 10.1021/acs.jproteome.5b00730. Epub 2015 Nov 18.


Distinct composition of human fetal HDL attenuates its anti-oxidative capacity.

Sreckovic I, Birner-Gruenberger R, Obrist B, Stojakovic T, Scharnagl H, Holzer M, Scholler M, Philipose S, Marsche G, Lang U, Desoye G, Wadsack C.

Biochim Biophys Acta. 2013 Apr;1831(4):737-46. doi: 10.1016/j.bbalip.2012.12.015. Epub 2013 Jan 13.


Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.

Smuts CM, Weich HF, Weight MJ, Faber M, Kruger M, Lombard CJ, Benadé AJ.

Coron Artery Dis. 1994 Apr;5(4):331-8.


Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties.

Gordon SM, McKenzie B, Kemeh G, Sampson M, Perl S, Young NS, Fessler MB, Remaley AT.

Mol Cell Proteomics. 2015 Dec;14(12):3247-57. doi: 10.1074/mcp.M115.054031. Epub 2015 Oct 19.


Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology.

Birner-Gruenberger R, Schittmayer M, Holzer M, Marsche G.

Prog Lipid Res. 2014 Oct;56:36-46. doi: 10.1016/j.plipres.2014.07.003. Epub 2014 Aug 6. Review.


Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions.

Tan Y, Liu TR, Hu SW, Tian D, Li C, Zhong JK, Sun HG, Luo TT, Lai WY, Guo ZG.

PLoS One. 2014 Apr 15;9(4):e94264. doi: 10.1371/journal.pone.0094264. eCollection 2014.


The measurement of high-density lipoprotein mediated cholesterol efflux from macrophage cells by liquid chromatography tandem mass spectrometry.

Wang M, Guo H, Wang S, Yang R, Li H, Zhao H, Wang S, Dong J, Chen W.

Cell Physiol Biochem. 2014;34(6):1901-11. doi: 10.1159/000366388. Epub 2014 Nov 21.


Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Hoofnagle AN, Wu M, Gosmanova AK, Becker JO, Wijsman EM, Brunzell JD, Kahn SE, Knopp RH, Lyons TJ, Heinecke JW.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2528-34. doi: 10.1161/ATVBAHA.110.212894. Epub 2010 Sep 16.


Inflammation alters HDL composition and function: implications for HDL-raising therapies.

Marsche G, Saemann MD, Heinemann A, Holzer M.

Pharmacol Ther. 2013 Mar;137(3):341-51. doi: 10.1016/j.pharmthera.2012.12.001. Epub 2012 Dec 14. Review.


Supplemental Content

Support Center